Julianne Bruno
Board Director
Julianne is a Growth Partner at Fairmount Funds Management LLC. Prior to joining Fairmount, she was a pivotal member of the CRISPR Therapeutics leadership team. During her six-year tenure with CRISPR, she served as the Program Leader across multiple hematology and oncology programs before taking on the role of Chief Operating Officer. In these roles, she oversaw the development of Casgevy™ and helped mature the operating model of the company. Julianne has also worked as a leader in the life sciences practice at McKinsey & Co. She received her A.B. from Princeton University and an MBA from the Wharton School, University of Pennsylvania.
